Pfizer (PFE) stock in focus as Sally Susman, the company's Chief Corporate Affairs Officer, plans to depart after 18 years.

NYC mayoral frontrunner Zohran Mamdani is expected to talk with NYC business leaders in a series of closed-door meetings next ...

One of the best known communications executives in corporate America, Susman worked at Pfizer for nearly two decades after ...

Ursula von der Leyen is expected to survive no confidence motion over secret texts with Pfizer CEO, but vote highlights ...

Pfizer chief corporate affairs officer Sally Susman is departing the company after roughly two decades, CEO Albert Bourla ...

Pfizer and other drug companies have met with the Trump administration to discuss lowering U.S. drug prices but no commitments have been made, Chief Executive Albert Bourla said on Monday. President ...

Pfizer has promoted Albert Bourla, seen as a likely successor to incumbent CEO Ian Read, to the newly-created role of chief operating officer. The move could help Read focus on long-term strategy ...

The House Judiciary Committee subpoenaed a former Pfizer executive who allegedly claimed senior members of the company ...

Shares of Pfizer offer a yield above 7% at recent prices. Pfizer is a pharmaceutical giant that has raised its dividend every ...

Motion was ‘taken from the oldest playbook of extremists," aimed at ‘polarizing society and eroding trust in democracy,’ says ...

Pfizer’s first quarter results drew a positive market response as management emphasized margin improvement and disciplined ...